From 9ac853c7ceece333099021974025d07e75be2b33 Mon Sep 17 00:00:00 2001 From: Johannes Ranke Date: Tue, 12 May 2020 08:07:07 +0200 Subject: Documentation improvements, rebuild static docs --- docs/reference/endpoints.html | 57 ++++++++++++++++++++++--------------------- 1 file changed, 29 insertions(+), 28 deletions(-) (limited to 'docs/reference/endpoints.html') diff --git a/docs/reference/endpoints.html b/docs/reference/endpoints.html index ef38c521..05d65191 100644 --- a/docs/reference/endpoints.html +++ b/docs/reference/endpoints.html @@ -11,23 +11,27 @@ with mkinfit — endpoints • mkin - + - + - + + + + + - - + + - + - - + + @@ -43,7 +47,6 @@ from kinetic models fitted with mkinfit. If the SFORB model was specified for one of the parents or metabolites, the Eigenvalues are returned. These are equivalent to the rate constantes of the DFOP model, but with the advantage that the SFORB model can also be used for metabolites." /> - @@ -61,7 +64,7 @@ advantage that the SFORB model can also be used for metabolites." /> - +
@@ -119,7 +122,12 @@ advantage that the SFORB model can also be used for metabolites." />
@@ -135,7 +143,7 @@ advantage that the SFORB model can also be used for metabolites." /> @@ -162,9 +170,9 @@ advantage that the SFORB model can also be used for metabolites.

Value

A list with a matrix of dissipation times named distimes, - and, if applicable, a vector of formation fractions named ff - and, if the SFORB model was in use, a vector of eigenvalues - of these SFORB models, equivalent to DFOP rate constants

+and, if applicable, a vector of formation fractions named ff +and, if the SFORB model was in use, a vector of eigenvalues +of these SFORB models, equivalent to DFOP rate constants

Note

The function is used internally by summary.mkinfit.

@@ -192,17 +200,10 @@ advantage that the SFORB model can also be used for metabolites.

- @@ -213,7 +214,7 @@ advantage that the SFORB model can also be used for metabolites.

-

Site built with pkgdown 1.4.1.

+

Site built with pkgdown 1.5.1.

-- cgit v1.2.1